Karyorrhexis

❧

Wikipedia

Apoptosis

Karyorrhexis (from Greek κάρυον karyon, "kernel, seed, nucleus," and ῥῆξις rhexis, "bursting") is the destructive fragmentation of the cell nucleus that occurs in a dying cell.[1] It is characterized by the breakdown of the nuclear envelope and the dispersal of condensed chromatin into the cytoplasm.[2] The process is usually preceded by pyknosis (irreversible chromatin condensation) and followed by karyolysis (enzymatic dissolution of chromatin). It may occur during programmed cell death (apoptosis), cellular senescence, or necrosis. [citation needed]

In apoptosis, karyorrhexis is mediated by Ca2+- and Mg2+-dependent endonucleases, ensuring that nuclear fragments are packaged into apoptotic bodies and removed by phagocytosis. In necrosis, by contrast, nuclear fragmentation occurs in a less orderly fashion, leaving behind cellular debris that can contribute to tissue damage and inflammation.[3]

Nuclear envelope dissolution

In the intrinsic pathway of apoptosis, cellular stressors such as oxidative stress activate pro-apoptotic members of the Bcl-2 protein family, leading to permeabilization of the mitochondrial outer membrane.[4] This releases cytochrome c into the cytoplasm, triggering a signaling cascade that culminates in the activation of multiple caspase enzymes.[4] Among these, caspase-6 cleaves nuclear lamina proteins such as lamin A/C, structural components that maintain the integrity of the nuclear envelope. Their cleavage facilitates the controlled dissolution of the nuclear envelope during apoptosis.[5]

Chromatin fragmentation

During karyorrhexis in apoptosis, nuclear DNA is cleaved in an orderly fashion by endonucleases such as caspase-activated DNase, producing discrete nucleosomal fragments.[6] This organization is possible because DNA has already undergone condensation during pyknosis, being tightly wrapped around histone proteins in repeating units of ≈180 bp. Activated endonucleases cleave the linker DNA between histones, generating short, regularly sized fragments that correspond to nucleosomal units.[7] These DNA fragments can be visualized by gel electrophoresis, where they produce a characteristic “ladder” pattern, a hallmark used to distinguish apoptosis from other forms of cell death.[8]

In other forms of cell death

In apoptosis, karyorrhexis is a controlled process in which caspases degrade lamin proteins, leading to the orderly breakdown of the nuclear envelope. In less regulated forms of cell death, such as necrosis, nuclear degradation occurs through different mechanisms. Necrotic cells are characterized by rupture of the plasma membrane, lack of caspase activation, and the induction of an inflammatory response.[3] Because necrosis is caspase-independent, the nucleus may remain intact during early stages before rupturing as a result of osmotic stress and membrane damage.

A specialized form of necrosis, necroptosis, involves a more regulated pathway but still results in plasma membrane rupture. Here, nuclear destabilization is mediated by the protease calpain, which cleaves lamins and promotes nuclear envelope breakdown.[3]

Unlike karyorrhexis in apoptosis, which generates apoptotic bodies subsequently removed by phagocytosis, karyorrhexis in necroptosis leads to the uncontrolled release of intracellular contents into the extracellular space, where they are cleared primarily through pinocytosis.[9]

Mechanism

Apoptotic pathways

Apoptosis, and the associated nuclear degradation through karyorrhexis, can be triggered by a variety of physiological and pathological stimuli. DNA damage, oxidative stress, hypoxia, and infections activate signaling cascades that converge on the intrinsic apoptotic pathway. This pathway may also be induced by external factors such as ethanol, which promotes activation of apoptosis-related proteins including BAX and caspases.[10]

In addition to intrinsic signals, activation of cell-surface death receptors such as CD95 can initiate the extrinsic apoptotic pathway, also resulting in caspase activation and nuclear envelope degradation.[5] In both pathways, executioner caspases, particularly caspase-3, cleave nuclear lamins and promote chromatin fragmentation, driving karyorrhexis.[3]

Necrotic pathways

In contrast to apoptosis, nuclear degradation during necrosis is a largely unregulated process. Necrotic cells are characterized by rupture of the plasma membrane, uncontrolled calcium influx, and activation of proteases such as calpain, which accelerate nuclear disintegration.[11] These features highlight the mechanistic differences between necrotic and apoptotic karyorrhexis.

Senescence and DNA damage response

The extent of DNA damage can also determine whether a cell undergoes apoptosis or enters cellular senescence. Senescence involves a permanent cessation of cell division and is typically observed after approximately 50 doublings in primary cells.[12]

One major cause of senescence is telomere shortening, which triggers a persistent DNA damage response (DDR). This response activates the kinases ATR and ATM, which in turn activate Chk1 and Chk2. These signaling events stabilize the transcription factor p53. When DNA damage is mild, p53 induces CIP proteins that inhibit CDKs, enforcing cell-cycle arrest. In cases of severe DNA damage, however, p53 activates apoptotic pathways, leading to caspase activity and nuclear envelope dissolution via karyorrhexis.[13]

Clinical significance

Karyorrhexis is a hallmark of cell death observed in a range of pathological conditions, including ischemia and neurodegenerative disorders. It has been documented in myocardial infarction and stroke, where nuclear fragmentation contributes to tissue damage during acute stress responses.[14] In obstetric pathology, placental vascular malperfusion has been linked to karyorrhexis and implicated in cases of fetal demise, reflecting its role in disrupted tissue homeostasis.[15]

In oncology, apoptotic karyorrhexis has a dual significance. On one hand, it contributes to controlled cell death and tumor suppression; on the other, resistance to apoptosis allows cancer cells to evade this process, promoting malignancy. Therapeutic strategies that target apoptotic pathways aim to restore nuclear degradation and trigger tumor regression.[16]

See also

References

  1. ↑ Zamzami N, Kroemer G (September 1999). "Condensed matter in cell death". Nature. 401 (6749): 127–128. Bibcode:1999Natur.401..127Z. doi:10.1038/43591. PMID 10490018. S2CID 36673000.
  2. ↑ Advances in Mutagenesis Research. Springer Science & Business Media. 2012. p. 11. ISBN 978-3-642-78193-3. Retrieved 11 November 2017.
  3. 1 2 3 4 Nikoletopoulou V, Markaki M, Palikaras K, Tavernarakis N (December 2013). "Crosstalk between apoptosis, necrosis and autophagy". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833 (12): 3448–3459. doi:10.1016/j.bbamcr.2013.06.001. PMID 23770045.
  4. 1 2 Kaloni D, Diepstraten ST, Strasser A, Kelly GL (February 2023). "BCL-2 protein family: attractive targets for cancer therapy". Apoptosis. 28 (1–2): 20–38. doi:10.1007/s10495-022-01780-7. PMC 9950219. PMID 36342579.
  5. 1 2 Lindenboim L, Zohar H, Worman HJ, Stein R (2020-04-27). "The nuclear envelope: target and mediator of the apoptotic process". Cell Death Discovery. 6 (1) 29. doi:10.1038/s41420-020-0256-5. PMC 7184752. PMID 32351716.
  6. ↑ Nagata S (April 2000). "Apoptotic DNA fragmentation". Experimental Cell Research. 256 (1): 12–18. doi:10.1006/excr.2000.4834. PMID 10739646.
  7. ↑ Arends MJ, Morris RG, Wyllie AH (March 1990). "Apoptosis. The role of the endonuclease". The American Journal of Pathology. 136 (3): 593–608. PMC 1877493. PMID 2156431.
  8. ↑ Gong J, Traganos F, Darzynkiewicz Z (May 1994). "A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry". Analytical Biochemistry. 218 (2): 314–319. doi:10.1006/abio.1994.1184. PMID 8074286.
  9. ↑ Wu Y, Dong G, Sheng C (September 2020). "Targeting necroptosis in anticancer therapy: mechanisms and modulators". Acta Pharmaceutica Sinica. B. 10 (9): 1601–1618. doi:10.1016/j.apsb.2020.01.007. PMC 7563021. PMID 33088682.
  10. ↑ Fernández-Solà J (February 2020). "The Effects of Ethanol on the Heart: Alcoholic Cardiomyopathy". Nutrients. 12 (2): 572. doi:10.3390/nu12020572. PMC 7071520. PMID 32098364.
  11. ↑ Priante G, Gianesello L, Ceol M, Del Prete D, Anglani F (July 2019). "Cell Death in the Kidney". International Journal of Molecular Sciences. 20 (14): 3598. doi:10.3390/ijms20143598. PMC 6679187. PMID 31340541.
  12. ↑ Hayflick L, Moorhead PS (December 1961). "The serial cultivation of human diploid cell strains". Experimental Cell Research. 25 (3): 585–621. doi:10.1016/0014-4827(61)90192-6. PMID 13905658.
  13. ↑ Surova O, Zhivotovsky B (August 2013). "Various modes of cell death induced by DNA damage". Oncogene. 32 (33): 3789–3797. doi:10.1038/onc.2012.556. PMID 23208502.
  14. ↑ Zhang D, Jiang C, Feng Y, Ni Y, Zhang J (July 2020). "Molecular imaging of myocardial necrosis: an updated mini-review". Journal of Drug Targeting. 28 (6): 565–573. doi:10.1080/1061186X.2020.1725769. PMID 32037899.
  15. ↑ Stanek J, Drach A (March 2022). "Placental CD34 immunohistochemistry in fetal vascular malperfusion in stillbirth". The Journal of Obstetrics and Gynaecology Research. 48 (3): 719–728. doi:10.1111/jog.15169. PMID 35092332.
  16. ↑ Wong RS (September 2011). "Apoptosis in cancer: from pathogenesis to treatment". Journal of Experimental & Clinical Cancer Research. 30 (1) 87. doi:10.1186/1756-9966-30-87. PMC 3197541. PMID 21943236.